Does Cigna Cover Wegovy? (2026): Your Plan, the Rules, and Your Next Move
By The RX Index Editorial Team — a pricing intelligence and comparison resource for GLP-1 telehealth providers.
Published: · Last reviewed:
Reviewed monthly or when Cigna revises its Wegovy policies.
Some links on this page are affiliate links. We may earn a commission if you choose a featured provider, at no extra cost to you. Our coverage facts come from Cigna's published policies, the FDA, Novo Nordisk, and CMS. We do not change our recommendations based on payouts.
The short answer
Does Cigna cover Wegovy? Sometimes — and the honest answer depends on your specific pharmacy benefit, the Cigna policy your plan uses, and whether your employer purchased weight-loss medication coverage. The two policies that drive most decisions are IP0206 (standard — BMI ≥30, or BMI ≥27 with one weight-related comorbidity) and IP0621 (benefit-exclusion override — BMI ≥32, or BMI ≥27 with two comorbidities plus a lifestyle-vendor engagement requirement).
The move is not "submit and hope." Find your coverage bucket first, then have your prescriber submit the prior authorization (PA) against that bucket. If your plan flat-out excludes weight-loss drugs, PA paperwork won't fix it — but there are still four real paths to FDA-approved Wegovy, including the Evernorth $200/month cap (EncircleRx), the Wegovy Savings Card stacked on commercial coverage (as low as $25/month), NovoCare Pharmacy direct ($149–$399/month depending on dose and formulation), and Ro Body ($39 for the first month).
Reported coverage data: more than 50% of Evernorth pharmacy benefit clients reportedly cover weight-management drugs like Wegovy, but coverage among Cigna Healthcare's smaller-employer health-benefits clients is much lower — closer to 15–20%. Your employer's plan design still decides your answer.
Fastest path: free Cigna Wegovy coverage check
Ro runs a free GLP-1 Insurance Coverage Checker that contacts your insurance plan and sends a personalized report showing GLP-1 coverage details, cost estimates when available, and whether prior authorization is required. Use it as your coverage check, then confirm the exact Cigna policy with HR or your prescriber's portal before submission.
Check My Cigna Wegovy Coverage Free with Ro → (sponsored affiliate link, opens in a new tab)Sponsored affiliate link. Ro Body membership is separate from the free coverage check.
Does Cigna cover Wegovy? Find your situation in this table
There are six buckets you can fall into. Find your bucket, and the answer becomes specific.
| Your Cigna situation | Likely coverage stance | Confidence |
|---|---|---|
| Large employer commercial plan with Evernorth-administered pharmacy benefit | More likely covered with PA (Evernorth reports >50% of its plans cover weight-loss drugs) | Medium |
| Small employer commercial plan | Less likely covered (~15–20% of Cigna Healthcare's smaller-employer plans cover weight-loss drugs) | Medium |
| Self-funded ASO plan (your employer hires Cigna as administrator only) | Your employer decides — Cigna is a vendor | High |
| Cigna ACA / Individual & Family Plan | Generally excluded — Cigna policy explicitly says weight-loss meds are "specifically excluded under many benefit plans" | High |
| Cigna Medicare Advantage (Cigna Healthspring) | Not covered for weight loss today — but the federal Medicare GLP-1 Bridge opens July 1, 2026 with $50/month copay for eligible members | High |
| Cigna Medicare Advantage + established cardiovascular disease + overweight/obesity | Possibly covered now under Part D for the cardiovascular indication (not the weight-loss indication) | Medium |
The fastest way to find your bucket is to look at your formulary on myCigna and call member services. We give you the exact script in the call script section below.
Why Cigna, Express Scripts, and Evernorth are usually the same coverage decision
Cigna and Express Scripts share the same corporate roof. Cigna Group owns Evernorth, which owns Express Scripts (your pharmacy benefit manager — the company that runs the drug list and processes pharmacy claims). For most Cigna-administered plans, Express Scripts manages the pharmacy benefit, which means a Wegovy claim or prior authorization routes through Express Scripts using Cigna's formulary and PA rules. So in practice, "does Cigna cover Wegovy" and "does Express Scripts cover Wegovy" are often the same question.
There's one important caveat. Cigna's own policy documents note that plan documents control coverage, and that some Cigna companies provide utilization review services without making the final coverage determination. Translation: your employer's plan document can override Cigna's standard formulary, and if your plan is self-funded ASO, your employer — not Cigna — has the final say on benefit design.
- • When Cigna tells you "your pharmacy benefit is managed by Express Scripts," that's the corporate structure, not a runaround. Both teams share medical reviewers and PA criteria.
- • The $200/month cap program (EncircleRx) that Evernorth launched in May 2025 is a pharmacy benefit option Express Scripts sells to employers — not a clinical change to Cigna's PA rules. Your employer either bought EncircleRx or they didn't.
- • Express Scripts denials and Cigna denials go to the same appeals path. The appeal goes to Express Scripts Clinical Appeals (exact address in the denial section below).
Which Cigna Wegovy prior authorization policy applies to your plan?
Cigna runs multiple Wegovy-related coverage policies. The two that drive most coverage decisions — and the ones almost every competing article misses or misstates — are IP0206 (the standard weight-loss GLP-1 PA policy) and IP0621 (the benefit-exclusion override policy). Both are effective April 30, 2026.
Policy IP0206 — the standard one most people fall under
Adult criteria for initial approval:
- Age ≥18
- At least 3 months of documented behavior modification and dietary restriction
- Either baseline BMI ≥30 kg/m² alone, OR baseline BMI ≥27 kg/m² with at least one weight-related comorbidity: hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease, knee osteoarthritis, asthma, COPD, MASLD/NAFLD, PCOS, or coronary artery disease
- Will be used alongside diet and lifestyle modification
Initial approval: 8 months. Renewal: 1 year with documented ≥5% body weight loss from baseline. Source: Cigna Policy IP0206 (effective 04/30/2026).
Policy IP0621 — the stricter override version
This policy applies when your employer's plan normally excludes anti-obesity drugs but added a "benefit exclusion override" rider. It's stricter on purpose.
Adult criteria for initial approval:
- Age ≥18
- At least 3 months of documented behavior modification and dietary restriction
- Either baseline BMI ≥32 kg/m² alone, OR baseline BMI ≥27 kg/m² with at least TWO weight-related comorbidities from the same list
- Will be used alongside diet and lifestyle modification
- Additional requirement: enrollment and engagement in Cigna's standard lifestyle vendor program, including four weigh-ins and four app engagements per month
Initial approval: 8 months. Renewal: 1 year with documented ≥5% body weight loss from baseline. Source: Cigna Policy IP0621 (effective 04/30/2026).
IP0206 vs. IP0621 side-by-side
| Criterion | IP0206 (Standard) | IP0621 (Exclusion Override) |
|---|---|---|
| BMI alone path | ≥30 kg/m² | ≥32 kg/m² |
| BMI + comorbidities path | ≥27 kg/m² + 1 comorbidity | ≥27 kg/m² + 2 comorbidities |
| Comorbidity list | HTN, T2D, dyslipidemia, OSA, CVD, knee OA, asthma, COPD, MASLD/NAFLD, PCOS, CAD | Same list |
| Behavior/diet trial | ≥3 months, documented | ≥3 months, documented |
| Lifestyle-vendor engagement | Not specifically required | Required: 4 weigh-ins + 4 app engagements per month |
| Initial approval | 8 months | 8 months |
| Renewal | 1 year, requires ≥5% weight loss | 1 year, requires ≥5% weight loss |
| Source | Cigna Policy IP0206 (effective 04/30/2026) | Cigna Policy IP0621 (effective 04/30/2026) |
The one sentence nobody else publishes clearly: If your employer's Cigna plan normally excludes weight-loss medications but added a benefit-exclusion override, your prior authorization will be reviewed under IP0621 — which is materially stricter than the standard policy. A BMI of 28 with one comorbidity that would approve under IP0206 will not approve under IP0621, and the IP0621 path adds an ongoing monthly engagement requirement most patients never hear about until they're already enrolled in the medication.
How to figure out which policy applies to your plan
Ask HR
They have the plan documents and they know whether the employer purchased the AOM rider, the exclusion override, EncircleRx, or none of the above. This is the single most reliable source.
Call Cigna member services
Use the 10-question script below. The key question is whether your plan covers anti-obesity medications 'standardly' or 'through an exclusion override or EncircleRx program.'
Check the prescription drug list (PDL) on myCigna.com
If Wegovy appears with a 'PA' code, your plan likely has standard coverage. If Wegovy doesn't appear at all but a separate 'weight management' program does, you may be on an override or EncircleRx path.
Ready to find out where you stand with Cigna?
Ro's free GLP-1 Insurance Coverage Checker contacts your insurance plan and sends a personalized report showing GLP-1 coverage details, cost estimates when available, and whether prior authorization is required. Use it as your coverage check — then confirm the exact Cigna policy with HR or your prescriber's portal before your doctor submits.
Check Cigna Coverage Free with Ro → (sponsored affiliate link, opens in a new tab)Sponsored affiliate link. Ro Body membership starts at $39 for the first month, $149/month ongoing, or as low as $74/month with annual prepay. Medication cost is separate.
What your doctor actually has to submit — the PA evidence checklist
A clean Cigna prior authorization is not "patient wants Wegovy." It is a packet that mirrors Cigna's exact criteria. The strongest PAs document each requirement line by line so the medical reviewer has nothing to question. The weakest PAs get rejected for "insufficient documentation" — the most fixable bucket if the benefit exists in your plan.
| Required evidence | Why Cigna needs it | Who pulls it together |
|---|---|---|
| Baseline BMI from a date-stamped clinic visit (before any GLP-1 therapy) | Both IP0206 and IP0621 require baseline BMI as the entry threshold | Your prescriber's chart |
| Current weight + height | Needed for medical record and to calculate any change | Clinic vitals |
| Comorbidity documentation with ICD-10 codes (HTN, T2D, OSA, dyslipidemia, etc.) | Required if using the BMI 27+comorbidity pathway. For IP0621, you need TWO | Problem list / labs / sleep study report |
| 3+ months of documented behavior modification and reduced-calorie diet | Required for initial approval under both policies | Chart notes, dietitian notes, Noom/WW enrollment, exercise logs |
| Current medication list | Confirms no concurrent GLP-1 or other weight-loss medication (Cigna does not approve concomitant use) | Prescriber's EHR |
| FDA-approved indication on the prescription | Cigna's PA framework is organized by indication — weight loss, MACE, or MASH | Your prescriber writes this on the Rx |
| For IP0621 only: lifestyle-vendor enrollment with 4 weigh-ins + 4 app engagements/month | Required for ongoing IP0621 coverage | You + Cigna's lifestyle vendor program |
| For renewal: documented ≥5% body weight loss from baseline | Required for 1-year continuation under both policies | Clinic vitals at renewal visit |
| Prior weight-loss attempts (Saxenda, generic liraglutide, etc.) | Helps preempt step therapy denials when applicable | Prescriber chart |
The "3 months of behavior modification" rule is more flexible than it sounds. Cigna doesn't require a specific program. What they require is documentation. Dietitian visits count. Weight-loss program enrollment counts. Chart notes that say "patient counseled on diet and exercise on [date]" count. What doesn't count is "patient has tried diet and exercise" with no dates. Get the dates on the chart.
The most fixable denials live in this packet. When Wegovy is covered by your plan but the PA gets rejected, it's usually a documentation gap — missing baseline BMI, missing comorbidity ICD-10 codes, or a thin behavioral-modification record. A clean re-submission with the same plan often gets approved.
The Evernorth $200/month cap (EncircleRx) — how to tell if you're in
EncircleRx caps your out-of-pocket Wegovy cost at $200/month for participating plans — saving eligible members up to $3,600 per year compared to direct manufacturer pricing.
As of early 2025, EncircleRx covered roughly 9 million members and had saved enrolled plans approximately $200 million since launch. In May 2025, Evernorth expanded the program with direct negotiated deals with Novo Nordisk and Eli Lilly to deepen the savings.
Your employer decides whether you're in it
EncircleRx is opt-in for plan sponsors. Ask your HR team: "Are we enrolled in the Evernorth EncircleRx GLP-1 cost-cap program?" That single question gives you the answer in 30 seconds.
The $200 cap is a price ceiling, not a replacement for approval rules
You still need to meet the PA criteria. The cap kicks in after you're approved. EncircleRx plans sometimes use a BMI 35-style policy or a separate program-specific path. Ask whether your plan uses IP0206, IP0621, or an EncircleRx-specific policy.
The $200 counts toward your annual deductible
Unlike most manufacturer copay assistance, EncircleRx dollars actually accrue toward your deductible and out-of-pocket maximum. That's a feature Evernorth specifically designed in.
Does Cigna cover Wegovy for heart disease or cardiovascular risk reduction?
Yes, under a separate pathway with separate documentation. Wegovy injection is FDA-approved to reduce the risk of major adverse cardiovascular events (MACE) in adults with established cardiovascular disease and either obesity or overweight.
This matters in two specific situations. Situation 1: Your Cigna plan excludes weight-loss meds but you have cardiovascular disease. Some Cigna plans that won't cover Wegovy for obesity will cover it for MACE reduction if the cardiovascular indication is documented. Situation 2: You're on Cigna Medicare Advantage. The MACE indication is a separate Part D-eligible use — some Cigna Medicare Advantage plans cover Wegovy injection for established CV disease + obesity or overweight under standard Part D today.
Cigna's medical reviewers cite the SELECT trial (n=17,604), which showed roughly a 20% relative reduction in MACE with Wegovy 2.4 mg vs. placebo over a mean 39.8 months of follow-up. If your prescriber submits the MACE PA, expect them to reference SELECT in the letter of medical necessity.
Do not pursue this pathway unless the diagnosis is clinically true and documented. Misrepresenting an indication is insurance fraud. The right move is to ask your prescriber: "Given my history, does the cardiovascular indication for Wegovy apply to me?"
Does Cigna cover Wegovy for MASH or NASH?
Yes, with strict documentation requirements. Wegovy injection is FDA-approved for non-cirrhotic MASH (formerly NASH) with moderate to advanced liver fibrosis — specifically stages F2 to F3.
Accepted documentation methods for MASH fibrosis staging:
- Liver biopsy (gold standard if performed within the last 3 years)
- Vibration-controlled transient elastography (VCTE / FibroScan)
- Magnetic resonance elastography (MRE)
- Enhanced Liver Fibrosis (ELF) blood test, cutoff of 9.2 for F2 fibrosis detection
Cigna's policy specifies that Wegovy for MASH must be prescribed by or in consultation with a hepatologist or other physician who specializes in the condition. Your primary care doctor can prescribe Wegovy for weight loss; for the MASH indication, you typically need a hepatology consult on file. This pathway opens Wegovy access for a meaningful number of Cigna members who have liver disease and didn't realize they had a separate coverage route.
Does Cigna cover the Wegovy pill (tablet)?
Increasingly, yes — but verify the formulation separately. The Wegovy tablet (semaglutide, supplied in 1.5 mg, 4 mg, 9 mg, and 25 mg strengths) was FDA-approved for adults in late 2025. A 2026 Cigna drug-list change document added "WEGOVY TABLET" as a preferred-brand Tier 2 item on at least one Cigna Healthcare prescription drug list. What's tricky: coverage of the injection doesn't guarantee coverage of the tablet (and vice versa). They're listed as separate line items on most drug lists.
| Formulation | FDA-approved uses | What to verify on your plan |
|---|---|---|
| Wegovy injection (0.25, 0.5, 1, 1.7, 2.4 mg pens) | Weight reduction (adults + ages 12+), MACE risk reduction, non-cirrhotic MASH with F2–F3 fibrosis | Tier, PA, quantity limit, in-network specialty pharmacy |
| Wegovy HD (7.2 mg) | Weight reduction in adults (launched April 7, 2026; highest available dose) | Same checks; HD is a step-up dose, not a starter dose |
| Wegovy tablet (1.5, 4, 9, 25 mg) | Weight reduction; 25 mg is the adult maintenance dose; cardiovascular indication also referenced | Verify tablet line-item coverage separately from the injection; PA criteria typically mirror the injection |
Exact question to ask Cigna:
"Is Wegovy tablet covered under my plan separately from Wegovy injection? If yes, what tier is it, does it require prior authorization, and does the PA use the same criteria as Wegovy injection?"
Does Cigna Medicare cover Wegovy?
Generally no for weight loss before July 1, 2026 — and yes for cardiovascular risk reduction in some cases today.
The Medicare GLP-1 Bridge opens July 1, 2026. This is a federal CMS demonstration running July 1, 2026 through December 31, 2027. Eligible Medicare Part D beneficiaries can get Wegovy (injection or tablet), Foundayo (orforglipron tablets), or Zepbound KwikPen at a flat $50/month copay regardless of dose.
CMS Bridge eligibility criteria:
| Condition | BMI requirement |
|---|---|
| No additional condition needed | BMI ≥35 |
| HFpEF, uncontrolled hypertension, or CKD stage 3a | BMI ≥30 |
| Prediabetes, previous MI, previous stroke, or symptomatic PAD | BMI ≥27 |
Two important caveats: the $50 copay does not count toward your Part D deductible or the new $2,100 annual out-of-pocket cap, and the Bridge sunsets December 31, 2027 with no clearly defined permanent successor.
Cigna Medicare Advantage member? Ro's published policy is that it does not coordinate GLP-1 coverage for government insurance plans (with a limited federal employee exception). Instead: (1) check CMS Bridge eligibility with your prescriber, (2) call your Cigna Medicare Advantage plan and ask about Part D coverage for the cardiovascular risk reduction indication, and (3) talk to your doctor about the documentation the Bridge will require for July 1, 2026 enrollment.
What you'll actually pay each month — every realistic scenario
The advertised list price for Wegovy is around $1,350/month. Almost nobody pays that. Here's the realistic math, dose by dose, verified May 14, 2026.
| Your situation | Starter (0.25–0.5 mg) | Maintenance injection | Wegovy tablet | Wegovy HD 7.2 mg |
|---|---|---|---|---|
| Covered + PA approved + Savings Card stacked | as low as $25/month | as low as $25/month | as low as $25/month | as low as $25/month |
| Covered + PA approved + employer in EncircleRx | flat $200/month | $200/month | $200/month | $200/month |
| Covered + PA approved + standard specialty tier | $50–$350/month | $50–$350/month | $50–$350/month | $50–$350/month |
| Excluded + NovoCare Pharmacy direct cash-pay | $199 first 2 fills for 0.25–0.5 mg pens (through 6/30/2026), then $349/month | $349/month | $149/month for 1.5 mg or 4 mg; $299/month for 9 mg or 25 mg | $399/month |
| Excluded + Medicare Bridge (after 7/1/2026, if eligible) | $50/month | $50/month | $50/month | $50/month |
| No insurance / Medicaid / TRICARE | NovoCare cash-pay prices above (savings card not eligible) | Same | Same | Same |
Offer terms can change; verify current NovoCare pricing at NovoCare.com before relying on a specific number. The Wegovy Savings Card is the cheapest legitimate path if you have commercial insurance and your plan covers Wegovy — enroll at NovoCare.com or text SAVE to 83757. Medicare, Medicaid, and TRICARE beneficiaries cannot use it.
If Cigna denies Wegovy — the 8 denial reasons and what to do for each
A Cigna Wegovy denial can mean two very different things: a benefit-design exclusion or a fixable documentation/criteria problem. The denial letter decides which one you're dealing with.
| Denial reason | What it usually means | Best next action | What makes it fixable |
|---|---|---|---|
| Plan exclusion — anti-obesity meds not covered | Your employer didn't buy AOM coverage. The benefit doesn't exist for weight-loss use. | Ask HR if a mid-year exception is possible (rare); pivot to cash-pay or Medicare Bridge; note open enrollment date | Generally not fixable through medical-necessity appeal if the benefit is excluded |
| Step therapy required — must try Saxenda or generic liraglutide first | Policy requires a preferred-product trial first | Document contraindication or prior failure; physician submits formulary exception | Fixable if you can document why the preferred drug failed, isn't tolerated, or is contraindicated |
| Criteria not met — BMI documentation insufficient | Baseline BMI missing or below threshold for your policy | Physician resubmits with date-stamped clinic vitals; confirm IP0206 vs IP0621; if IP0621 + BMI 28, you need TWO comorbidities | Fixable if a clinic-documented baseline BMI exists and the threshold is genuinely met |
| Criteria not met — comorbidity documentation missing | Your comorbidities weren't on the chart or weren't in the policy's accepted list | Physician adds ICD-10 codes for HTN, T2D, OSA, dyslipidemia, CVD, etc.; for IP0621 confirm TWO are documented | Fixable if the diagnoses genuinely exist in your chart |
| Behavioral/dietary modification trial not documented | No record of 3 months of lifestyle change | Add dietitian notes, Noom/WW enrollment proof, exercise logs the clinician will sign off on | Fixable if any documented diet/exercise effort exists in your records |
| Initial vs. continuation pathway error | Submitted under the wrong PA pathway | Resubmit under correct pathway with prior fill history | Almost always fixable — administrative correction |
| Not medically necessary (vague) | Usually a documentation thinness issue | Request the criteria they used (written), then physician submits a Letter of Medical Necessity that mirrors criteria line by line; request a peer-to-peer review | Fixable if your case actually meets the policy criteria once they're laid out plainly |
| External review / IRO upheld denial | Internal appeals exhausted | Federal external review if ERISA-governed; state external review otherwise | Outcomes vary; may still be reviewable, especially when documentation gaps are addressed |
Where to send your Wegovy appeal:
- Express Scripts Clinical Appeals Department, PO Box 66588, St. Louis, MO 63166-6588
- Fax: 877-852-4070
- First-level internal appeal deadline: 180 calendar days from the date on the denial letter
Use the timeline printed on your denial letter or PA notice as the controlling timeline — not a generic web estimate.
The under-used weapon: peer-to-peer review. Most denials labeled "not medically necessary" can be reversed when your prescriber requests a direct call with Cigna's medical reviewer. Your prescriber's office initiates this, not you. If your first appeal is denied, ask your prescriber to schedule a peer-to-peer.
If your Cigna plan has a true weight-loss drug exclusion baked into the benefit design, no appeal letter is going to fix it. Medical necessity appeals work when there's a benefit to access; they don't create a benefit that doesn't exist. If you're in that bucket, the right next move is to either pursue a separate FDA-approved indication that your diagnosis genuinely supports (cardiovascular or MASH), switch plans at open enrollment, or use one of the cash-pay paths below.
Already denied and not sure what to do next?
Ro's insurance team can help with insurance paperwork and prior-authorization support when coverage is available on your plan. Before enrolling specifically for a denial, confirm whether your denial type is something Ro can support — a true plan exclusion may not be fixable through appeal regardless of who handles the paperwork.
See How Ro Handles Insurance → (sponsored affiliate link, opens in a new tab)Sponsored affiliate link.
If your plan won't cover Wegovy — the cash-pay paths that still work
Four real paths to FDA-approved Wegovy without Cigna coverage, ranked by what most people will actually use:
Path 1: NovoCare Pharmacy direct (cheapest)
Novo Nordisk's own direct-to-consumer pharmacy ships FDA-approved Wegovy at flat dose-based prices. No insurance involved, no prior authorization needed, no membership fees.
- $199/month for new patients on 0.25 mg or 0.5 mg injection for the first 2 fills (through June 30, 2026)
- $349/month for 0.25–2.4 mg injection ongoing
- $399/month for Wegovy HD 7.2 mg
- $149/month for Wegovy tablet 1.5 mg or 4 mg
- $299/month for Wegovy tablet 9 mg or 25 mg
Best fit: you already have a Wegovy prescription from your own doctor and want the cheapest legitimate route. Order direct at NovoCare.com. Offer terms can change — verify the current price for your specific dose before ordering. Not generally available to government insurance enrollees.
Path 2: Ro Body — cash-pay with clinician support
Ro is a telehealth provider that prescribes FDA-approved Wegovy (pill, pen, and HD), Foundayo, Zepbound, and Ozempic, and runs an insurance team that handles Cigna prior authorizations when coverage is available on commercial plans.
- Membership: $39 for the first month, $149/month ongoing, or as low as $74/month with annual plan paid upfront
- Medication cost: separate from membership; matches NovoCare pricing for Wegovy ($149–$399/month depending on dose)
- What's included: licensed provider visits, dose titration, insurance support, lab work if needed, ongoing messaging
Best fit: you don't have a prescriber yet, you want clinical oversight, or you want someone to handle the Cigna paperwork without doing dozens of follow-up calls. Note: Ro does not beat NovoCare on the raw medication price if you already have a prescription. If you have your own prescriber and you're going cash-pay, skip Ro entirely and order direct from NovoCare.com — you'll save the $149/month membership.
See Ro's Current Wegovy Program → (sponsored affiliate link, opens in a new tab)Sponsored affiliate link.
Path 3: NovoCare direct-pay when you have partial insurance
The same NovoCare Pharmacy direct-pay structure also activates when your insurance is in place but doesn't cover Wegovy. You don't use insurance; you pay the flat dose-based price directly through Novo Nordisk's pharmacy. Same prices ($149–$399/month depending on dose and formulation). Government insurance excluded.
Path 4: Switch plans at open enrollment
If your employer's Cigna plan permanently excludes Wegovy, your highest-leverage move is switching plans during open enrollment. Note your enrollment window, then verify each option's Wegovy coverage in writing before switching — verbal confirmations from call centers are unreliable. Look for "anti-obesity medications," "AOM benefits," or "GLP-1 coverage" in the plan documents.
A note on compounded semaglutide: We don't feature compounded providers on this page. Compounded semaglutide is not Wegovy and is not an FDA-approved finished product. This page is about FDA-approved Wegovy and Cigna coverage, so we don't route readers to compounded providers here. If you're interested in the compounded option, that's a separate conversation to have with your prescriber.
The exact call script: 10 questions for Cigna member services
Print this. Read it word-for-word. Call the number on the back of your Cigna ID card and ask for the pharmacy benefit department. Get a reference number for the call.
1. "Is Wegovy on my plan's formulary, or is it excluded?"
2. "If it's on the formulary, what tier is the injection on? What tier is the tablet on? Are they tiered differently?"
3. "Is prior authorization required? Which Cigna coverage policy does my plan use — IP0206, IP0621, or another (such as an EncircleRx-specific policy)?"
4. "Is there a step therapy requirement? If yes, what drugs must I try first?"
5. "Is my plan administered by Express Scripts as the pharmacy benefit manager?"
6. "Is my employer enrolled in the Evernorth EncircleRx GLP-1 cost-cap program that limits monthly cost to $200?"
7. "What is my expected copay or coinsurance if Wegovy is approved? Does my plan have a deductible to satisfy first?"
8. "Does my plan require a specialty pharmacy, or can I fill at retail?"
9. "If I'm denied, what are the appeal levels and deadlines specific to my plan?"
10. "Can you send me written confirmation of what we discussed today, with the reference number for this call?"
Also call your HR benefits team and ask:
"I need to verify three things about our pharmacy benefit: First, does our plan cover anti-obesity medications including Wegovy? Second, did we purchase the standard formulary or one with an exclusion override rider? Third, are we enrolled in EncircleRx for the $200/month GLP-1 cap?"
HR has a copy of the plan documents on file and can usually answer in 5 minutes.
What real Cigna members say
Pulled from Reddit's r/WegovyWeightLoss community as voice-of-customer signals, not as medical or efficacy evidence. The point isn't what worked or didn't — it's that the confusion is widespread.
"Prior authorization process with Cigna ... they wouldn't give me the details of the criteria for the PA."
— Reddit user, r/WegovyWeightLoss
"I asked if this could get pre-authorization and they said no, it's not covered at all."
— Reddit user, r/WegovyWeightLoss
"How do you demonstrate weight loss effort? They want documentation for at least 3 months and I don't know what counts."
— Reddit user, r/WegovyWeightLoss
Two patterns show up over and over: Cigna call-center reps often won't share the specific PA criteria with members directly (your prescriber has to look them up on the provider portal), and the "3 months of behavior modification" requirement is the single most common documentation gap. The fix for both is the same: get your prescriber to submit the PA against the specific policy that applies to your plan, with documentation that mirrors the policy language line by line.
How we verified everything on this page
We don't use ghostwriters. We don't claim a doctor reviewed this page when one didn't. We tell you what we actually did so you can sanity-check us.
| What we verified | Source / method |
|---|---|
| Cigna PA policies IP0206 and IP0621 (BMI thresholds, comorbidity lists, lifestyle-vendor requirement, approval durations) | Pulled directly from static.cigna.com on May 14, 2026. Both have effective dates of April 30, 2026. |
| NovoCare Pharmacy self-pay pricing for Wegovy injection and tablet | Verified at NovoCare.com on May 14, 2026 (tablet pricing: $149/month for 1.5 mg or 4 mg; $299/month for 9 mg or 25 mg). |
| CMS Medicare GLP-1 Bridge launch date, drug list, eligibility criteria, and $50/month copay structure | Confirmed from the CMS website. |
| Evernorth EncircleRx member counts and savings figures | Cross-referenced against Evernorth's May 2025 announcement and subsequent reporting in Healthcare Dive, Becker's Payer Issues, and Fierce Healthcare. |
| Cigna Customer Appeal Request form and Express Scripts Clinical Appeals submission process | Reviewed from Cigna's provider portal. |
| FDA labeling for Wegovy injection and tablet | Reviewed current FDA prescribing information for both formulations. |
| Ro's GLP-1 Insurance Coverage Checker functionality and government-insurance limitation | Confirmed from Ro's published program page on May 14, 2026. |
What we couldn't verify for every reader:
- Your specific Cigna plan's benefit design (only your HR and your plan documents have this)
- Whether your employer purchased the AOM rider, the exclusion override, EncircleRx, or none of the above
- Your specific deductible, copay, or coinsurance
- The quality of any specific prescriber's PA submission
- Whether your medical history supports the MACE or MASH indication
- Whether Ro, NovoCare, Cigna, or CMS pricing or policy changed after our May 14, 2026 verification date
Changelog: Initial publication May 14, 2026. We update this page monthly or whenever Cigna revises IP0206 or IP0621, NovoCare changes pricing, the Medicare GLP-1 Bridge rules change, or Ro updates its insurance policy.
FAQ
Does Cigna cover Wegovy for weight loss?
Some Cigna plans cover Wegovy for weight loss with prior authorization, and many don't. Coverage depends on whether your specific plan includes anti-obesity medication benefits. Reporting suggests more than 50% of Evernorth pharmacy clients cover weight-management drugs, but only about 15–20% of Cigna Healthcare's smaller-employer health-benefits clients do. ACA marketplace plans and most Cigna Medicare Advantage plans generally exclude Wegovy for weight loss.
Does Cigna require prior authorization for Wegovy?
When Wegovy is covered under the Cigna GLP-1 policies reviewed here, prior authorization generally applies. A plan exclusion is different from a PA requirement, and some cases route through separate policies such as EncircleRx, cardiovascular-risk reduction, MASH/NASH, Individual & Family Plan, or the Medicare GLP-1 Bridge.
What BMI does Cigna require to approve Wegovy?
Under Cigna Policy IP0206 (standard), baseline BMI ≥30 alone, or ≥27 with one weight-related comorbidity. Under Cigna Policy IP0621 (benefit exclusion override), baseline BMI ≥32 alone, or ≥27 with at least two weight-related comorbidities — and IP0621 adds a lifestyle-vendor engagement requirement (4 weigh-ins + 4 app engagements per month). Most articles online describe only IP0206.
What comorbidities count for Cigna Wegovy coverage?
Cigna's listed comorbidities are hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease, knee osteoarthritis, asthma, COPD, MASLD/NAFLD, PCOS, and coronary artery disease. The same list applies to both IP0206 and IP0621.
How long does Cigna prior authorization take for Wegovy?
Cigna and Express Scripts response timelines depend on the request type, plan, and whether the request is urgent. Use the timeline printed on your denial letter or PA notice as the controlling timeline. Express Scripts clinical appeals materials list a 180-day appeal window from the denial date.
How long is an initial Cigna Wegovy approval good for?
Under the IP0206 and IP0621 adult weight-loss pathways, initial approval is 8 months. For 1-year renewal, you must document at least 5% body weight loss from baseline. Other pathways (EncircleRx-style, MACE, MASH, Medicare Bridge) may use different windows.
Does Cigna cover the Wegovy pill or tablet?
Yes on many plans, but it's listed separately from the injection on most formularies. A 2026 Cigna drug-list change document added Wegovy tablet as a Tier 2 preferred brand on at least one Cigna Healthcare drug list. The 25 mg tablet is the adult maintenance dose. Always verify coverage of both the injection and the tablet on your specific plan.
Does Cigna cover Wegovy HD (7.2 mg)?
Yes — Wegovy HD is covered as a Wegovy formulation under both IP0206 and IP0621. Your prescriber must document medical necessity for stepping up from the standard 2.4 mg dose. Wegovy HD is not a starter dose.
Does Cigna cover Wegovy for heart disease?
Yes, under the cardiovascular risk reduction indication. Wegovy injection is FDA-approved to reduce major adverse cardiovascular events in adults with established CV disease (prior MI, prior stroke, or symptomatic PAD) plus obesity or overweight. Cigna's PA pathway for this indication requires the cardiovascular diagnosis to be clinically documented.
Does Cigna cover Wegovy for MASH or NASH?
Yes, with strict documentation. Cigna's MASH pathway requires adult status, non-cirrhotic disease, and documented F2/F3 fibrosis via liver biopsy, VCTE, MRE, or ELF blood test. The prescription must come from or be co-signed by a physician who specializes in the condition.
Does Cigna Medicare cover Wegovy?
Generally no for weight loss before July 1, 2026, when the federal Medicare GLP-1 Bridge opens at $50/month copay for eligible Part D members who meet CMS criteria (age ≥18 plus BMI ≥35, or BMI ≥30 with HFpEF/uncontrolled hypertension/CKD stage 3a, or BMI ≥27 with prediabetes/MI/stroke/PAD). Some Cigna Medicare Advantage plans currently cover Wegovy injection under standard Part D for the cardiovascular risk reduction indication in members with established CV disease.
Can I use the Wegovy Savings Card with Cigna?
Yes if you have a commercial Cigna plan that covers Wegovy. The card can bring eligible patients to as low as $25/month (current Novo terms cap savings around $100/month per fill; verify at NovoCare.com). Medicare, Medicaid, and TRICARE members are excluded by federal anti-kickback law.
Does the Cigna $200/month cap apply to all Cigna plans?
No. The $200 cap is part of Evernorth's EncircleRx program, which is an opt-in pharmacy benefit option employers buy separately. Ask your HR team whether your plan is enrolled.
Why did Cigna deny my Wegovy prescription?
A Cigna Wegovy denial can mean a benefit-design exclusion (the plan doesn't cover weight-loss meds at all) or a fixable documentation/criteria problem. Get the denial in writing and identify which bucket applies — your next action depends on it.
Can I appeal a Cigna Wegovy denial?
Yes. You have 180 days from the denial date to file the first internal appeal with Express Scripts Clinical Appeals. Response timelines depend on the request type — use the timeline on your denial letter as the controlling timeline. If the internal appeal is upheld, you can request external review by an Independent Review Organization.
How much does Wegovy cost without Cigna coverage?
List price is around $1,350/month, but NovoCare Pharmacy direct sells Wegovy at $149–$399/month depending on dose and formulation (verified May 14, 2026). Commercial insurance with the savings card stacked can drop the out-of-pocket cost to as low as $25/month.
Can Ro help with Cigna Wegovy coverage?
Ro's free GLP-1 Insurance Coverage Checker contacts your insurance plan and sends a personalized report showing GLP-1 coverage details, cost estimates when available, and whether prior authorization is required. If you enroll in Ro Body ($39 first month, $149/month ongoing, or as low as $74/month with annual prepay), Ro's insurance team supports the prior authorization on commercial plans. Ro does not currently coordinate coverage for government insurance plans (Medicare, Medicaid, TRICARE) outside a limited federal employee exception.
Still not sure which path fits you?
Take our free 60-second matching quiz. We'll ask 5 questions about your plan type, BMI, comorbidities, and goal — then return a personalized recommendation with the exact next step. No email required.
Find My GLP-1 Path — 60-Second Quiz →Check Cigna Wegovy coverage free with Ro
If you already know you want help running your Cigna prior authorization on a commercial plan, Ro's free GLP-1 Insurance Coverage Checker is the fastest way to find out where you stand and get the paperwork started. Ro Body starts at $39 for the first month and includes the free coverage checker, prior authorization support, and (if covered) ongoing care to keep your Wegovy approved at renewal.
Check Cigna Wegovy Coverage Free with Ro → (sponsored affiliate link, opens in a new tab)Sponsored affiliate link.
Related Cigna and Wegovy guides
- → GLP-1 Providers That Accept Cigna: 5 Paths — the provider-routing companion to this insurance page
- → Wegovy Savings Card 2026: Qualify, Cost, and Enroll
- → Does Medicare Cover Wegovy for Weight Loss? 2026
- → Best Telehealth for Wegovy: 7 Options in 2026
- → Wegovy HD vs Wegovy Pill: Which Is Right for You?
- → GLP-1 With UnitedHealthcare: Every Path in 2026
- → GLP-1 Providers That Accept Blue Cross: 7 Options
- → Does TRICARE Cover GLP-1? Wegovy, Ozempic & Zepbound 2026